the trampcol regimen merits further evaluation in cgl after acute transformation , as a primary treatment for aml , and as therapy for all 1 ) in relapse , 2 ) in adults , 3 ) in children with adverse prognostic features , and 4 ) in t-cell all .
C0023449
all
C1961099
t-cell all